教育背景

澳門(mén)城市大學(xué)、分析心理學(xué)博士

臨床經(jīng)歷

1、（2007.08-2020.08）北京回龍觀醫(yī)院副主任醫(yī)師

2、（2020.08-2023.11）；北京朝陽(yáng)醫(yī)院副主任醫(yī)師

3、（2023.12-至今）北京朝陽(yáng)醫(yī)院主任醫(yī)師

教學(xué)、科研簡(jiǎn)介

1.碩士研究生導(dǎo)師；發(fā)表的論文：1.Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-na?ve patients with schizophrenia, Journal of Psychiatric Research, 2021 (140) 409–415.

2.Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia:A longitudinal follow-up, Psychoneuroendocrinology  133 (2021) 105392-15397.

3.Tumor necrosis factor-alpha -1031T/C polymorphism is associated with cognitive deficits in chronic schizophrenia patients versus healthy controls. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2018(177B):379-387.

4.Interleukin-3, symptoms and cognitive deficits in first-episode drug-na?ve and chronic medicated schizophrenia. Psychiatry Res. 2018,(263):147-163.

5.Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychology. Journals of Psychiatric Research, 2012(46):1093-1098.

6.Comparison of Residual Depressive Symptoms, Functioning, and Quality of Life Between Patients with Recurrent Depression and First Episode Depression After Acute Treatment in China. Neuropsychiatr Dis Treat. 2021 Oct 1;17:3039-3051.

社會(huì)或?qū)W會(huì)兼職

1、首都醫(yī)科大學(xué)心理學(xué)系常委

2、北京醫(yī)學(xué)會(huì)抑郁障礙分會(huì)委員

3、北京市朝陽(yáng)區(qū)醫(yī)學(xué)會(huì)精神衛(wèi)生分會(huì)委員

榮譽(yù)（所獲獎(jiǎng)項(xiàng)）

北京醫(yī)學(xué)科技獎(jiǎng)三等獎(jiǎng)（2021.07）